This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Canine Tumor Necrosis Factor Ligand Superfamily Member (TNLG6A)
Product Overview
BioVenic's Recombinant Canine Tumor Necrosis Factor Ligand Superfamily Member (TNLG6A) is a recombinant protein expressed from E.coli. Its predicted molecular weight is 32.6 kDa. The purity is>97% (SDS-PAGE).
Specifications
Target Information
Canine tumor necrosis factor ligand superfamily member is part of the TNF superfamily, which plays a crucial role in regulating immune responses, inflammation, and cell survival. This protein is involved in various biological processes, including the activation of immune cells and the modulation of apoptosis. It can promote or inhibit tumor growth depending on the context, making it significant in cancer research and therapy. Additionally, it is implicated in bone metabolism and may influence conditions like arthritis and osteoporosis in dogs.
Shipping and Storage
This product is shipped with dry ice. It is recommended to aliquote as needed and store at -80°C upon receipt. Reconstituted protein solution can be stored at 4°C for 1 week, at < -80°C for 12 months.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL.Aliquote the reconstituted solution to minimise freeze-thaw cycles.